The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global One-stop Pharmacy Research CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global One-stop Pharmacy Research CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1772980

No of Pages : 124

Synopsis
The global One-stop Pharmacy Research CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

A one-stop pharmacy research CDMO refers to a contract development and manufacturing organization that provides a full range of pharmaceutical research services. It provides a package solution from drug discovery, drug development to pre-clinical trial research to accelerate the development process of new drugs.

A one-stop pharmacy research CDMO usually covers the following services: drug discovery, pharmacological research, drug formulation development, synthesis and analytical method development, adverse event reporting and monitoring, pre-clinical trial research, GMP manufacturing. By providing a full range of pharmaceutical research services, the one-stop pharmacy research CDMO can help pharmaceutical companies shorten the R&D cycle, reduce R&D costs, improve product quality, and provide integrated solutions to provide comprehensive support for the R&D work of pharmaceutical companies.

The Global Info Research report includes an overview of the development of the One-stop Pharmacy Research CDMO industry chain, the market status of Innovative Drugs (API+Preparation, API+Intermediate+Preparation), Generic Drugs (API+Preparation, API+Intermediate+Preparation), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of One-stop Pharmacy Research CDMO.

Regionally, the report analyzes the One-stop Pharmacy Research CDMO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global One-stop Pharmacy Research CDMO market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the One-stop Pharmacy Research CDMO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the One-stop Pharmacy Research CDMO industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., API+Preparation, API+Intermediate+Preparation).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the One-stop Pharmacy Research CDMO market.

Regional Analysis: The report involves examining the One-stop Pharmacy Research CDMO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the One-stop Pharmacy Research CDMO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to One-stop Pharmacy Research CDMO:

Company Analysis: Report covers individual One-stop Pharmacy Research CDMO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards One-stop Pharmacy Research CDMO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Innovative Drugs, Generic Drugs).

Technology Analysis: Report covers specific technologies relevant to One-stop Pharmacy Research CDMO. It assesses the current state, advancements, and potential future developments in One-stop Pharmacy Research CDMO areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the One-stop Pharmacy Research CDMO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

One-stop Pharmacy Research CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type

  • API+Preparation
  • API+Intermediate+Preparation

Market segment by Application

  • Innovative Drugs
  • Generic Drugs
  • Improved Drugs
  • Others

Market segment by players, this report covers

  • Medicilon
  • Gliead
  • Boehringer Ingelheim
  • Vertex
  • Mirati Therapeutics
  • AMPAC
  • Pfizer
  • Polypeptide
  • Bachem
  • Merck
  • Asymchem
  • Zhejiang Langhua Pharmaceutical
  • Viva Biotech
  • Zhejiang Jiuzhou Pharmaceutical
  • Shanghai Porton Zhihui Biopharmaceutical
  • Boji Pharmaceutical Technology
  • GenScript ProBio
  • Asymchem Laboratories (Tianjin)
  • Beijing Sun-novo Pharmaceutical Research
  • Arthur Pharma

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe One-stop Pharmacy Research CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of One-stop Pharmacy Research CDMO, with revenue, gross margin and global market share of One-stop Pharmacy Research CDMO from 2018 to 2023.
Chapter 3, the One-stop Pharmacy Research CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and One-stop Pharmacy Research CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of One-stop Pharmacy Research CDMO.
Chapter 13, to describe One-stop Pharmacy Research CDMO research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of One-stop Pharmacy Research CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of One-stop Pharmacy Research CDMO by Type
1.3.1 Overview: Global One-stop Pharmacy Research CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global One-stop Pharmacy Research CDMO Consumption Value Market Share by Type in 2022
1.3.3 API+Preparation
1.3.4 API+Intermediate+Preparation
1.4 Global One-stop Pharmacy Research CDMO Market by Application
1.4.1 Overview: Global One-stop Pharmacy Research CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Innovative Drugs
1.4.3 Generic Drugs
1.4.4 Improved Drugs
1.4.5 Others
1.5 Global One-stop Pharmacy Research CDMO Market Size & Forecast
1.6 Global One-stop Pharmacy Research CDMO Market Size and Forecast by Region
1.6.1 Global One-stop Pharmacy Research CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global One-stop Pharmacy Research CDMO Market Size by Region, (2018-2029)
1.6.3 North America One-stop Pharmacy Research CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe One-stop Pharmacy Research CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific One-stop Pharmacy Research CDMO Market Size and Prospect (2018-2029)
1.6.6 South America One-stop Pharmacy Research CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa One-stop Pharmacy Research CDMO Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Medicilon
2.1.1 Medicilon Details
2.1.2 Medicilon Major Business
2.1.3 Medicilon One-stop Pharmacy Research CDMO Product and Solutions
2.1.4 Medicilon One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medicilon Recent Developments and Future Plans
2.2 Gliead
2.2.1 Gliead Details
2.2.2 Gliead Major Business
2.2.3 Gliead One-stop Pharmacy Research CDMO Product and Solutions
2.2.4 Gliead One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gliead Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim One-stop Pharmacy Research CDMO Product and Solutions
2.3.4 Boehringer Ingelheim One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Vertex
2.4.1 Vertex Details
2.4.2 Vertex Major Business
2.4.3 Vertex One-stop Pharmacy Research CDMO Product and Solutions
2.4.4 Vertex One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Vertex Recent Developments and Future Plans
2.5 Mirati Therapeutics
2.5.1 Mirati Therapeutics Details
2.5.2 Mirati Therapeutics Major Business
2.5.3 Mirati Therapeutics One-stop Pharmacy Research CDMO Product and Solutions
2.5.4 Mirati Therapeutics One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Mirati Therapeutics Recent Developments and Future Plans
2.6 AMPAC
2.6.1 AMPAC Details
2.6.2 AMPAC Major Business
2.6.3 AMPAC One-stop Pharmacy Research CDMO Product and Solutions
2.6.4 AMPAC One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AMPAC Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer One-stop Pharmacy Research CDMO Product and Solutions
2.7.4 Pfizer One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Polypeptide
2.8.1 Polypeptide Details
2.8.2 Polypeptide Major Business
2.8.3 Polypeptide One-stop Pharmacy Research CDMO Product and Solutions
2.8.4 Polypeptide One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Polypeptide Recent Developments and Future Plans
2.9 Bachem
2.9.1 Bachem Details
2.9.2 Bachem Major Business
2.9.3 Bachem One-stop Pharmacy Research CDMO Product and Solutions
2.9.4 Bachem One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bachem Recent Developments and Future Plans
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck One-stop Pharmacy Research CDMO Product and Solutions
2.10.4 Merck One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck Recent Developments and Future Plans
2.11 Asymchem
2.11.1 Asymchem Details
2.11.2 Asymchem Major Business
2.11.3 Asymchem One-stop Pharmacy Research CDMO Product and Solutions
2.11.4 Asymchem One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Asymchem Recent Developments and Future Plans
2.12 Zhejiang Langhua Pharmaceutical
2.12.1 Zhejiang Langhua Pharmaceutical Details
2.12.2 Zhejiang Langhua Pharmaceutical Major Business
2.12.3 Zhejiang Langhua Pharmaceutical One-stop Pharmacy Research CDMO Product and Solutions
2.12.4 Zhejiang Langhua Pharmaceutical One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhejiang Langhua Pharmaceutical Recent Developments and Future Plans
2.13 Viva Biotech
2.13.1 Viva Biotech Details
2.13.2 Viva Biotech Major Business
2.13.3 Viva Biotech One-stop Pharmacy Research CDMO Product and Solutions
2.13.4 Viva Biotech One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Viva Biotech Recent Developments and Future Plans
2.14 Zhejiang Jiuzhou Pharmaceutical
2.14.1 Zhejiang Jiuzhou Pharmaceutical Details
2.14.2 Zhejiang Jiuzhou Pharmaceutical Major Business
2.14.3 Zhejiang Jiuzhou Pharmaceutical One-stop Pharmacy Research CDMO Product and Solutions
2.14.4 Zhejiang Jiuzhou Pharmaceutical One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
2.15 Shanghai Porton Zhihui Biopharmaceutical
2.15.1 Shanghai Porton Zhihui Biopharmaceutical Details
2.15.2 Shanghai Porton Zhihui Biopharmaceutical Major Business
2.15.3 Shanghai Porton Zhihui Biopharmaceutical One-stop Pharmacy Research CDMO Product and Solutions
2.15.4 Shanghai Porton Zhihui Biopharmaceutical One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shanghai Porton Zhihui Biopharmaceutical Recent Developments and Future Plans
2.16 Boji Pharmaceutical Technology
2.16.1 Boji Pharmaceutical Technology Details
2.16.2 Boji Pharmaceutical Technology Major Business
2.16.3 Boji Pharmaceutical Technology One-stop Pharmacy Research CDMO Product and Solutions
2.16.4 Boji Pharmaceutical Technology One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Boji Pharmaceutical Technology Recent Developments and Future Plans
2.17 GenScript ProBio
2.17.1 GenScript ProBio Details
2.17.2 GenScript ProBio Major Business
2.17.3 GenScript ProBio One-stop Pharmacy Research CDMO Product and Solutions
2.17.4 GenScript ProBio One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 GenScript ProBio Recent Developments and Future Plans
2.18 Asymchem Laboratories (Tianjin)
2.18.1 Asymchem Laboratories (Tianjin) Details
2.18.2 Asymchem Laboratories (Tianjin) Major Business
2.18.3 Asymchem Laboratories (Tianjin) One-stop Pharmacy Research CDMO Product and Solutions
2.18.4 Asymchem Laboratories (Tianjin) One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Asymchem Laboratories (Tianjin) Recent Developments and Future Plans
2.19 Beijing Sun-novo Pharmaceutical Research
2.19.1 Beijing Sun-novo Pharmaceutical Research Details
2.19.2 Beijing Sun-novo Pharmaceutical Research Major Business
2.19.3 Beijing Sun-novo Pharmaceutical Research One-stop Pharmacy Research CDMO Product and Solutions
2.19.4 Beijing Sun-novo Pharmaceutical Research One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Beijing Sun-novo Pharmaceutical Research Recent Developments and Future Plans
2.20 Arthur Pharma
2.20.1 Arthur Pharma Details
2.20.2 Arthur Pharma Major Business
2.20.3 Arthur Pharma One-stop Pharmacy Research CDMO Product and Solutions
2.20.4 Arthur Pharma One-stop Pharmacy Research CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Arthur Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global One-stop Pharmacy Research CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of One-stop Pharmacy Research CDMO by Company Revenue
3.2.2 Top 3 One-stop Pharmacy Research CDMO Players Market Share in 2022
3.2.3 Top 6 One-stop Pharmacy Research CDMO Players Market Share in 2022
3.3 One-stop Pharmacy Research CDMO Market: Overall Company Footprint Analysis
3.3.1 One-stop Pharmacy Research CDMO Market: Region Footprint
3.3.2 One-stop Pharmacy Research CDMO Market: Company Product Type Footprint
3.3.3 One-stop Pharmacy Research CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global One-stop Pharmacy Research CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global One-stop Pharmacy Research CDMO Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global One-stop Pharmacy Research CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global One-stop Pharmacy Research CDMO Market Forecast by Application (2024-2029)
6 North America
6.1 North America One-stop Pharmacy Research CDMO Consumption Value by Type (2018-2029)
6.2 North America One-stop Pharmacy Research CDMO Consumption Value by Application (2018-2029)
6.3 North America One-stop Pharmacy Research CDMO Market Size by Country
6.3.1 North America One-stop Pharmacy Research CDMO Consumption Value by Country (2018-2029)
6.3.2 United States One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe One-stop Pharmacy Research CDMO Consumption Value by Type (2018-2029)
7.2 Europe One-stop Pharmacy Research CDMO Consumption Value by Application (2018-2029)
7.3 Europe One-stop Pharmacy Research CDMO Market Size by Country
7.3.1 Europe One-stop Pharmacy Research CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
7.3.3 France One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific One-stop Pharmacy Research CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific One-stop Pharmacy Research CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific One-stop Pharmacy Research CDMO Market Size by Region
8.3.1 Asia-Pacific One-stop Pharmacy Research CDMO Consumption Value by Region (2018-2029)
8.3.2 China One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
8.3.5 India One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
9 South America
9.1 South America One-stop Pharmacy Research CDMO Consumption Value by Type (2018-2029)
9.2 South America One-stop Pharmacy Research CDMO Consumption Value by Application (2018-2029)
9.3 South America One-stop Pharmacy Research CDMO Market Size by Country
9.3.1 South America One-stop Pharmacy Research CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa One-stop Pharmacy Research CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa One-stop Pharmacy Research CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa One-stop Pharmacy Research CDMO Market Size by Country
10.3.1 Middle East & Africa One-stop Pharmacy Research CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE One-stop Pharmacy Research CDMO Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 One-stop Pharmacy Research CDMO Market Drivers
11.2 One-stop Pharmacy Research CDMO Market Restraints
11.3 One-stop Pharmacy Research CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 One-stop Pharmacy Research CDMO Industry Chain
12.2 One-stop Pharmacy Research CDMO Upstream Analysis
12.3 One-stop Pharmacy Research CDMO Midstream Analysis
12.4 One-stop Pharmacy Research CDMO Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’